Eudaimonia Asset Management »

4d Molecular Therapeutics In shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 96k 31.86

More positions owned by Eudaimonia Asset Management

Super Micro Computer Common Stock (SMCI)
FTAI Aviation Common Stock (FIP)
Viking Therapeutics Common Stock (VKTX)
Applied Industrial Technologies Common Stock (AIT)
NEXTracker Common Stock (NXT)
Comfort Systems USA Common Stock (FIX)
Aaon Common Stock (AAON)
Leonardo SpA Common Stock (DRS)
Sweetgreen Common Stock (SG)
Dycom Industries Common Stock (DY)
Ryman Hospitality Properties Common Stock (RHP)
Installed Building Products Common Stock (IBP)
Crinetics Pharmaceuticals Common Stock (CRNX)
RxSight Common Stock (RXST)
Q2 Holdings Common Stock (QTWO)

View all positions for Eudaimonia Asset Management

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
VR Adviser
BlackRock
BVF
Henderson Group
Goldman Sachs Group
Viking Global Investors
Vanguard Group
Morgan Stanley
Redmile Group
Arrowpoint Asset Management
Braidwell
FMR
Geode Capital Management
Casdin Capital

View all funds holding 4d Molecular Therapeutics In